Click here to see Dr. Wang's complete list of publications.

  • E. Holmuhamedov, L. Wang and A. Terzic. ATP-sensitive K+ channel opener prevent Ca2+ overloaded in rat cardiac mitochondria. J. Physiol. 519:47-360, 1999.
  • L. Wang L Yan, C. Mcguir, C.A. Kozak, M. Wang, U.-J. Kim, M. Siciliano and R.M. Weinshilboum. Mouse histamine N-methyltransferase: cDNA cloning, expression, gene cloning and chromosomal localization. Inflammat. Res. 50:300-308, 2001.
  • L. Wang B. Thomae, B. Eckloff, E. Wieben and R.M. Weinshilboum. Human histamine N-methyltransferase pharmacogenetics: gene resequencing, promoter characterization, and functional studies of a common 5’-flanking region single nucleotide polymorphism (SNP). Biochem. Pharmacol. 64:699-710, 2002.
  • O.E. Salavaggione, L. Kidd, J.L. Prondzinski, C.L. Szumlanski, V. Shane Pankratz, L. Wang, L. Trepanier and R.M. Weinshilboum. Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics. Pharmacogenetics 12:713-724, 2002.
  • L. Wang, W. Sullivan, D. Toft and R.M. Weinshilboum. Thiopurine S-methyltransferase pharmacogenetics: association with chaperone proteins and relation to degradation. Pharmacogenetics 13:555-564, 2003.
  • R. Weinshilboum and L. Wang. Pharmacogenetics: inherited variation in amino acid sequence and altered protein quantity. Clin. Pharmacol. Ther. 75:253-258, 2004.
  • L. Wang, V.C. Yee and R.M. Weinshilboum. Human sulfotransferase (SULT1A3) pharmacogenetics: a model system for aggresome formation and accelerated degradation. Biochem. Biophys. Res. Commun. 325:426-433, 2004.
  • R. Weinshilboum and L. Wang. Pharmacogenomics: bench to bedside. Nature Rev. Drug Discovery 3:739-748, 2004. [reprinted in condensed form, in Discovery Medicine 5:30-36, 2005.]
  • L. Wang, T.V. Nguyen, R.W. McLaughlin, L.A. Sikkink, M. Ramirez-Alvarado and R.M. Weinshilboum. Human thiopurine S-methyltransferase (TPMT) pharmacogenetics: variant misfolding and aggresome formation. Proc. Natl. Acad. Sci. 102:9394-9399, 2005.
  • O.E. Salavaggione, L. Wang, M. Wiepert, V.C. Yee and R.M. Weinshilboum. Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics. Pharmacogenetics and Genomics 15:801-815, 2005.
  • C.X. Ma, A.A. Adjei, O.E. Salavaggione, L. Pelleymounter, L. Wang, B.W. Eckloff, D. Schaid, E.D. Wieben, A.A. Adjei and R.M. Weinshilboum. Human aromatase (CYP19) pharmacogenomics: gene resequencing and functional genomics. Cancer Res. 65:11071-11082, 2005.
  • Y. Ji, O.E. Salavaggione, L. Wang, A.A. Adjei, B. Eckloff, E.D. Wieben and R.M. Weinshilboum. Human phenylethanolamine N-methyltransferase pharmacogenomics: gene resequencing and functional genomics. J. Neurochem. 95:1766-1776, 2005.
  • T.C. Wood, O.E. Salavaggione, B. Mukherjee, L. Wang, A.F. Klumpp, B.A. Thomae, B.W. Eckloff, D.J. Schaid, E.D. Wieben and R.M. Weinshilboum. Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies. J. Biol. Chem. 281:7364-7373, 2006.
  • L. Wang and R. Weinshilboum. Thiopurine S-methyltransferase (TPMT) pharmacogenetics: a model for clinical and mechanistic pharmacogenetics studies. Oncogene 25:1629-1638, 2006.
  • R.M. Weinshilboum and L. Wang. Pharmacogenetics and pharmacogenomics: development, science and translation. Annu. Rev. Genomics & Hum. Genet. “in press”.